Kington Capital is the famous VC, which was founded in 2016. The venture was found in Asia in China. The main office of represented VC is situated in the Suzhou.
We also calculated 1 valuable employee in our database.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Kington Capital, startups are often financed by Sequoia Capital China, SBCVC. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Northern Light Venture Capital, YuanMing Capital. In the next rounds fund is usually obtained by 6 Dimensions Capital.
The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Gracell Biotechnologies, JW Therapeutics, SyMap Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
Funds with similar focus
|Accel X||Central, Central Region, Singapore|
|Belcube||Belgium, Brussels, Brussels Hoofdstedelijk Gewest|
|D'Ieteren||Belgium, Brussels, Brussels Hoofdstedelijk Gewest|
|Eli Lilly||Indiana, Indianapolis, United States|
|Hitachi Ventures||Bayern, Germany, München|
|Incutex Company Builders||Argentina, Córdoba, Cordoba|
|MetaStable Capital||California, San Francisco, United States|
|Ministry of Health Singapore||Central, Central Region, Singapore|
|REMUS Capital||Boston, Massachusetts, United States|
|Resources Connection||California, Costa Mesa, United States|
|Senshu Ikeda Holdings||Japan, Osaka, Osaka Prefecture|
|Teton Growth Partners||Jackson, United States, Wyoming|
|Think.Health||Bavaria, Bayern, Germany|
|VICTORIA Venture Capital SCR-Pyme S.A.||Barcelona, Catalonia, Spain|
|Vilitas GmbH & Co. KG||Aachen, Germany, Nordrhein-Westfalen|
|WDHB||Colorado, Denver, United States|
Qixin Micro Semiconductor
|13 Jun 2022||Suzhou, Jiangsu, China|
|$30M||01 Mar 2022||-|
Next Generation Gene Therapeutics
|$30M||22 Apr 2021||Suzhou, Jiangsu, China|
|$85M||25 Feb 2019||Gusu District, Jiangsu, China|
|$3M||29 Jan 2019||Gusu District, Jiangsu, China|
|$17M||26 Nov 2018||China, Jiangsu|
|$10M||12 Nov 2018||China, Jiangsu|
|$448K||20 Aug 2018||Futian District, Guangdong Province, China|
|$90M||07 Mar 2018||Shanghai, China|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.